http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002502409-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 |
filingDate | 1998-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002502409-A |
titleOfInvention | Use of anti-inflammatory steroids for the treatment of chronic inflammatory bowel disease |
abstract | (57) Summary The present invention relates to the use of an inflammatory compound having the general formula (I) for the manufacture of a medicament for chronic inflammatory bowel disease. In the general formula, X is one of a group consisting of H and halogen, and Y is a member of a group consisting of H 2 , H (OH), H (O (C 1-6 ) acyl) and O. One, R 1 is one of the group consisting of H, CH 3 and halogen, R 2 is (C 1-4 ) alkyl, R 3 is H, O ((C 1-6 ) acyl), O One of the group consisting of ((C 1-6 ) alkyl) and CH 3 , R 4 is one of the group consisting of H and (C 1-4 ) alkyl, and C 1 -C 2 and C 6 -C 7 is a saturated or unsaturated bond. |
priorityDate | 1997-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.